CN109876050A - Compound astragalus membranaceus liquid - Google Patents
Compound astragalus membranaceus liquid Download PDFInfo
- Publication number
- CN109876050A CN109876050A CN201910333463.2A CN201910333463A CN109876050A CN 109876050 A CN109876050 A CN 109876050A CN 201910333463 A CN201910333463 A CN 201910333463A CN 109876050 A CN109876050 A CN 109876050A
- Authority
- CN
- China
- Prior art keywords
- liquid
- astragalus membranaceus
- radix
- coptis
- compound astragalus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 23
- 235000006533 astragalus Nutrition 0.000 title claims abstract description 20
- 241000045403 Astragalus propinquus Species 0.000 title claims abstract description 19
- 150000001875 compounds Chemical class 0.000 title claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 20
- 244000247747 Coptis groenlandica Species 0.000 claims abstract description 16
- 235000002991 Coptis groenlandica Nutrition 0.000 claims abstract description 16
- 239000009636 Huang Qi Substances 0.000 claims abstract description 16
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 15
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 15
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 15
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 15
- 240000004980 Rheum officinale Species 0.000 claims abstract description 15
- 235000008081 Rheum officinale Nutrition 0.000 claims abstract description 15
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 13
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 13
- 241000756943 Codonopsis Species 0.000 claims abstract description 13
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims abstract description 12
- 229960005375 lutein Drugs 0.000 claims abstract description 12
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims abstract description 12
- 235000012680 lutein Nutrition 0.000 claims abstract description 12
- 239000001656 lutein Substances 0.000 claims abstract description 12
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims abstract description 12
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims abstract description 12
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 10
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229940116229 borneol Drugs 0.000 claims abstract description 10
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 10
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- 235000019441 ethanol Nutrition 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 2
- 239000011435 rock Substances 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 230000004438 eyesight Effects 0.000 abstract description 22
- 210000001508 eye Anatomy 0.000 abstract description 16
- 239000008280 blood Substances 0.000 abstract description 13
- 210000004369 blood Anatomy 0.000 abstract description 13
- 210000003205 muscle Anatomy 0.000 abstract description 7
- 229940079593 drug Drugs 0.000 abstract description 6
- 230000004436 pseudomyopia Effects 0.000 abstract description 6
- 210000005252 bulbus oculi Anatomy 0.000 abstract description 4
- 238000001035 drying Methods 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 230000017531 blood circulation Effects 0.000 abstract description 3
- 230000008092 positive effect Effects 0.000 abstract description 3
- 230000008961 swelling Effects 0.000 abstract description 3
- 206010014080 Ecchymosis Diseases 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract description 2
- 210000000744 eyelid Anatomy 0.000 abstract description 2
- 230000023597 hemostasis Effects 0.000 abstract description 2
- 230000001976 improved effect Effects 0.000 abstract description 2
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 230000003287 optical effect Effects 0.000 abstract description 2
- 230000001151 other effect Effects 0.000 abstract description 2
- 210000003800 pharynx Anatomy 0.000 abstract description 2
- 238000012545 processing Methods 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- 208000001491 myopia Diseases 0.000 description 14
- 230000004379 myopia Effects 0.000 description 13
- 238000000034 method Methods 0.000 description 6
- 238000002560 therapeutic procedure Methods 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 239000000571 coke Substances 0.000 description 3
- 230000002354 daily effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000010926 purge Methods 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 238000012937 correction Methods 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 208000014733 refractive error Diseases 0.000 description 2
- 238000011477 surgical intervention Methods 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000035568 catharsis Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 210000002189 macula lutea Anatomy 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000036578 sleeping time Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
A kind of compound astragalus membranaceus liquid, it is characterized in that, the compound astragalus membranaceus liquid is made of the raw material that following weight (part) matches: Radix Astragali, the coptis, Cortex Phellodendri, rheum officinale, safflower, cassia seed, Radix Angelicae Sinensis, pueraria lobata, Radix Codonopsis, lutein, borneol, we's tool heat-clearing and damp-drying drug, sore swollen toxin, hot eyes pharynx swelling, cooling blood and removing stasis hemostasis, removing blood stasis and acesodyne, heat-clearing improving eyesight, heat-clearing is scorching, ecchymosis is impermeable, tonifying middle-Jiao and Qi and other effects, to be applied on eyes, loosen inferior rectus muscle part on eyes, be improved the blood benign cycle of eyelid and eyeball, accelerate metabolism, alleviate eye muscle tensity, increase ball portions blood circulation, form eyeball own tension and muscle balance state, improve view optical axis away from, to treat pseudo-myopia, with positive effect, this prescription is common common traditional Chinese medicine, production cost is low, the processing is simple, make It is applied widely with simple, conveniently, convenient for storage and promote.
Description
Technical field
The present invention relates to technical field of traditional Chinese medicines more particularly to a kind of for treating the compound astragalus membranaceus liquid of pseudo-myopia.
Background technique
On July 24th, 2018, quality of elementary education monitoring center, the Ministry of Education issued " Chinese compulsory education quality-monitoring report
Accuse " in, it is indicated that the bad outstanding problem of student eyesight.Senior class, the bad recall rate of grade eight student eyesight be respectively 36.5%,
65.3%, wherein senior class schoolgirl eyesight moderate is bad and the bad ratio of severe is respectively 18.6%, 10.4%, and boy student is respectively
16.4%, 9%；Grade eight schoolgirl's eyesight moderate is bad and the bad ratio of severe is respectively 24.1%, 39.5%, and boy student is respectively
22.1%, 31.7%.Student's sleeping time is overall insufficient.
One research report of the World Health Organization shows that up to 600,000,000, adolescent myopia rate occupies China's glasses for the shortsighted person at present
The first in the world.The rate of myopia of high school student and university student more than seventy percent and have risen year by year, the rate of myopia of pupil also close to
40%, the teen-age overall vision situation in China is not allowed pessimistic as a result,.
Myopia has become a kind of a kind of ametropic disease that annoying many people in China, current main controlling party
Method has: optics correction of refractive errors, surgical intervention, pharmaceutical intervention (more depending on Western medicine), optics correction of refractive errors is mainly worn glasses, and one
Be it is inconvenient, dependence is strong when two, or even has the case where intensification, and surgical intervention, some types effect is relatively good, costly, tool
There is certain risk, pharmaceutical intervention depends on Western medicine more, and has certain side effect, and how unobvious effect is.
In the history of Chinese 5,000-year and down, Chinese medicine is the test that long-term treatment practice is stood in Chinese history,
In there are many Chinese herbal medicines to have the treatment of positive effect, especially pseudo-myopia to treatment myopia.
Summary of the invention
In view of the above deficiencies, the object of the present invention is to provide a kind of compound astragalus membranaceus liquid, Radix Astragali is selected, the coptis, Cortex Phellodendri, greatly
Huang, safflower, cassia seed, Radix Angelicae Sinensis, pueraria lobata, Radix Codonopsis, lutein are raw material, extract through decocting method, control pseudomyopia
Treating has good result.
To achieve the above object, the technical scheme adopted by the invention is that:
A kind of compound astragalus membranaceus liquid is made of the raw material that following weight (part) matches:
Radix Astragali 40-80, the coptis 20~60, Cortex Phellodendri 8-12, rheum officinale 8-12, safflower 8-12, cassia seed 8-12, Radix Angelicae Sinensis 8-12,
Pueraria lobata 8-12, Radix Codonopsis 8-12, lutein 8-12, borneol 8-12.
Further, the optimal weight (part) proportion is Radix Astragali 60, the coptis 40, Cortex Phellodendri 10, rheum officinale 10, safflower 10, certainly
Pine torch 10, Radix Angelicae Sinensis 10, pueraria lobata 10, Radix Codonopsis 10, lutein 10, borneol 10.
The production method of above-mentioned compound astragalus membranaceus liquid, comprising the following steps:
(1), Radix Astragali is taken, the coptis, Cortex Phellodendri, rheum officinale, safflower, cassia seed, Radix Angelicae Sinensis, pueraria lobata, Radix Codonopsis adds the water 100 of 10 times of amounts
It DEG C extracts 2 hours, it is spare to filter out medical fluid, obtains the dregs of a decoction；
(2), step (1) dregs of a decoction are taken, adds 100 DEG C of water of 8 times of amounts to extract 2 hours, it is spare to filter out medical fluid；
(3), merge step (1), (2) medical fluid, be concentrated into 80 DEG C of temperature, relative density 1.1~1.3 is cooled to room temperature, adds
Borneol, lutein and 2 times of amount ethyl alcohol stirrings, stand, and take supernatant, and recycling ethyl alcohol adds purified water to specified amount.
Further, the regulation medicine amount liquid is that every 100g Radix Astragali can prepare 3~5L medical fluid ratio.
The invention has the benefit that having heat-clearing and damp-drying drug, sore swollen toxin, mesh using compound astragalus membranaceus liquid made of this prescription
Red pharynx swelling, cooling blood and removing stasis hemostasis, removing blood stasis and acesodyne, heat-clearing improving eyesight, heat-clearing is scorching, and ecchymosis is impermeable, tonifying middle-Jiao and Qi and other effects, with application
In being loosened, inferior rectus muscle part on eyes on eyes, the blood benign cycle of be improved eyelid and eyeball accelerates new old
Eye muscle tensity is alleviated in metabolism, increases ball portions blood circulation, forms eyeball own tension and muscle balance shape
State improves view optical axis away to treat pseudo-myopia, with positive effect, this prescription is common common traditional Chinese medicine, production cost
It is low, the processing is simple, using simple, conveniently, applied widely, convenient for storage and promote.
Specific embodiment
In order to keep technical solution of the present invention more explicit, it is further elaborated combined with specific embodiments below:
A kind of compound astragalus membranaceus liquid of the present invention, is made of the raw material that following weight (part) matches: Radix Astragali 40-80, and the coptis 20~
60, Cortex Phellodendri 8-12, rheum officinale 8-12, safflower 8-12, cassia seed 8-12, Radix Angelicae Sinensis 8-12, pueraria lobata 8-12, Radix Codonopsis 8-12, lutein 8-
12, borneol 8-12, wherein optimal weight (part) proportion is Radix Astragali 60, the coptis 40, Cortex Phellodendri 10, rheum officinale 10, safflower 10, cassia seed
10, Radix Angelicae Sinensis 10, pueraria lobata 10, Radix Codonopsis 10, lutein 10, borneol 10.
The drug effect overview of above-mentioned prescription main Chinese medicinal materials is as follows:
Radix Astragali pus draining and toxin expelling, expelling pus and promoting granulation；Coptis heat-clearing and damp-drying drug, purging fire for removing toxin；Cortex Phellodendri heat-clearing and damp-drying drug, purging intense heat, except steaming, solution
Poison treats sore；Rheum officinale purges heat logical intestines, removing pattogenic heat from the blood and toxic material from the body, dispelling stasis of blood and stimulating the menstrual flow；Radix Angelicae Sinensis heat-clearing is scorching, brings down a fever except rash；Safflower blood circulation dissipates the stasis of blood
Analgesic；Cassia seed heat-clearing improving eyesight；Pueraria lobata rising Yang expelling pathogenic factors from muscles and skin；Radix Codonopsis is used for tonifying middle-Jiao and Qi, strengthening spleen and tonifying lung；Then property is bitter slightly cold opens for borneol
Key inducing resuscitation, clearing away heat to and alleviating pain；Lutein has important protective effect to the macula lutea in retina.The cooperation of each medicine, is let out with the monarch of Radix Astragali
The fire of coke, pueraria lobata let out the fire of the part of the body cavity above the diaphragm housing the heart and lungs, and the fire that Radix Angelicae Sinensis lets out lower coke is minister, and safflower is removed heat by catharsis the fire of three cokes, thermally conductive downlink, borneol sweet and cool-natured solution
Poison.The effect of all medicines gather heat clearing and blood stasis dispersing altogether, lead to menstruation regulating network, swelling and pain relieving, beneficial mesh production of sperm.In addition, rheum officinale, Cortex Phellodendri, Radix Angelicae Sinensis have
There is antibacterial, furthermore Radix Angelicae Sinensis external application may additionally facilitate the absorption of subcutaneous extvavasated blood, and rheum officinale contains Chrysophanol, can condensed capillary blood
Pipe.Heat clearing and blood stasis dispersing medical fluid is directly externally applied at eyes, can improve histiocytic permeability, is conducive to drug absorption, enhances eye
Portion's microcirculation system improves its curative effect.
Embodiment 1
Radix Astragali 60g, coptis 40g, Cortex Phellodendri 10g, rheum officinale 10g, safflower 10g, cassia seed 10g, Radix Angelicae Sinensis 10g, pueraria lobata 10g are taken,
Radix Codonopsis 10g.
Add water 3L, 100 DEG C are extracted 2 hours, and it is spare to filter out medical fluid A；
The dregs of a decoction are taken, water 2.5L is added, 100 DEG C are extracted 2 hours, and it is spare to filter out medical liquid B；
Merge medical fluid A, B, is concentrated into 80 DEG C of temperature, relative density 1.2, after being cooled to room temperature, 10g on the rocks, lutein
10g, ethyl alcohol 5L are stirred, and are stood, and supernatant is taken, and recycling ethyl alcohol adds purified water, obtains compound astragalus membranaceus liquid 4L；
Take compound astragalus membranaceus liquid, with gauze be carrier with soak eyes at, per dressing everyday twice to vision restoration.
Embodiment 2
Take coptis astragalus 40g, coptis 20g, Cortex Phellodendri 8g, rheum officinale 8g, safflower 8g, cassia seed 8g, Radix Angelicae Sinensis 8g, pueraria lobata 8g, party
Join 8g；
The preparation method is the same as that of Example 1, obtains compound astragalus membranaceus liquid, at soak eyes.
Embodiment 3
Radix Astragali 80g, coptis 60g, Cortex Phellodendri 12g, rheum officinale 12g, safflower 12g, cassia seed 12g, Radix Angelicae Sinensis 12g, pueraria lobata 12g are taken,
Radix Codonopsis 12g.
The preparation method is the same as that of Example 1, obtains compound astragalus membranaceus liquid, at soak eyes.
It is close in school to 40 from May 6,18 days to 2018 March in 2018 in order to objectively evaluate clinical effectiveness of the present invention
Whole follow-up acquisition data are carried out depending on patient student, and have carried out data analysis, analysis result is as follows:
In 40, wherein male 25, female 15, the age 5-16 years old, once in the morning and once at night sticks, 20 minutes every time, imitate
Fruit is effective 38, invalid 2, effective percentage 95%.
It is analyzed as follows in more detail:
Analysis of cases one: wherein 9 myopia of student situations national standard vision Test Table detection under eyesight status 0.8
More than, wherein male student 6, Female student 3, the age between 6---14 years old,
Method: Chinese herb medicine eye paste soak therapy twice daily, 20 minutes or more every time
As a result: passing through one month, 60 Chinese traditional medicine wet compress therapies, wherein 9 low degree short sightedness student's whole eyesights are promoted to state
1.0 or more standard of family；Eyes 1.2 or more 4 are promoted to, 1.5 eyesight 1 of eyes is promoted to.
Analysis of cases two, wherein 7 myopia of student situations eyesight status under the detection of national standard vision Test Table exist
Between 0.4--0.8, medium myopia；Wherein male student 5, Female student 2, the age was between 5---13 years old
Method: Chinese traditional medicine wet compress therapy twice daily, 20 minutes or more every time
As a result: treatment is by March 18th, 2018 to May 6, by one month 60 times Chinese traditional medicine wet compress therapies, wherein 7
Wherein 15 years old student eyesight restores to eyes 1.2 medium myopia student, wherein 6 students have different degrees of vision restoration,
In a student eyesight without significant change；
Analysis of cases three, wherein 24 myopia of student situations eyesight status under the detection of national standard vision Test Table exist
0.4 hereinafter, height degree myopia；Wherein male student 13, Female student 11, the age between 8---16 years old,
Method: Chinese traditional medicine wet compress therapy twice daily, 20 minutes or more every time
As a result: treatment is by March 18th, 2018 to May 6, by one month, 60 Chinese traditional medicine wet compress therapies, wherein 24
Wherein obviously wherein 1 student is without significant change relatively for 6 student eyesights recoveries by name medium myopia student, and 17 student eyesights are not
It is promoted with degree；
It can be seen that there is good result to the treatment of teenage pseudomyopia from treatment results.
Above embodiment only examples made by the present invention to clearly illustrate, not limiting the scope of the present invention,
Anyone can obtain other various forms of variations or variation under the inspiration of the present invention, it is all thus amplify out it is apparent
Variation or variation, be within the scope of the present invention.
Claims (4)
1. a kind of compound astragalus membranaceus liquid, which is characterized in that the compound astragalus membranaceus liquid is made of the raw material that following weight (part) matches:
Radix Astragali 40-80, the coptis 20~60, Cortex Phellodendri 8-12, rheum officinale 8-12, safflower 8-12, cassia seed 8-12, Radix Angelicae Sinensis 8-12, pueraria lobata
8-12, Radix Codonopsis 8-12, lutein 8-12, borneol 8-12.
2. compound astragalus membranaceus liquid according to claim 1, it is characterised in that: weight (part) proportion is Radix Astragali 60, the coptis
40, Cortex Phellodendri 10, rheum officinale 10, safflower 10, cassia seed 10, Radix Angelicae Sinensis 10, pueraria lobata 10, Radix Codonopsis 10, lutein 10, borneol 10.
3. compound astragalus membranaceus liquid according to claim 1, it is characterised in that: the preparation of the coptis liquid includes the following steps:
(1), Radix Astragali is taken, the coptis, Cortex Phellodendri, rheum officinale, safflower, cassia seed, Radix Angelicae Sinensis, pueraria lobata, Radix Codonopsis adds 100 DEG C of water of 10 times of amounts to mention
It takes 2 hours, it is spare to filter out medical fluid, obtains the dregs of a decoction；
(2), step (1) dregs of a decoction are taken, adds 100 DEG C of water of 8 times of amounts to extract 2 hours, it is spare to filter out medical fluid；
(3), merge step (1), (2) medical fluid, be concentrated into 80 DEG C of temperature, relative density 1.1~1.3 is cooled to room temperature, on the rocks
Piece, lutein and 2 times of amount ethyl alcohol stirrings, stand, and take supernatant, and recycling ethyl alcohol adds purified water to specified amount.
4. compound astragalus membranaceus liquid according to claim 3, which is characterized in that the regulation medicine amount liquid is that every 100g Radix Astragali can be made
Standby 3~5L medical fluid ratio.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910333463.2A CN109876050A (en) | 2019-04-24 | 2019-04-24 | Compound astragalus membranaceus liquid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910333463.2A CN109876050A (en) | 2019-04-24 | 2019-04-24 | Compound astragalus membranaceus liquid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109876050A true CN109876050A (en) | 2019-06-14 |
Family
ID=66938319
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201910333463.2A Pending CN109876050A (en) | 2019-04-24 | 2019-04-24 | Compound astragalus membranaceus liquid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109876050A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110227122A (en) * | 2019-07-31 | 2019-09-13 | 郑州巨人生化集团有限公司 | A kind of Chinese medicine external composition and preparation method thereof for eliminating fundus macular degeneration |
| CN110433232A (en) * | 2019-09-03 | 2019-11-12 | 深圳市中康生物制药有限公司 | A kind of compound huang lian granules of external application and preparation method thereof |
| CN112891439A (en) * | 2019-11-18 | 2021-06-04 | 惠州市华达生物科技有限公司 | Compound pipewort liquid |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1091947A (en) * | 1993-05-05 | 1994-09-14 | 朱吉林 | Photoelectric glasses for myoporthosis |
| CN103054998A (en) * | 2013-01-29 | 2013-04-24 | 陆杰 | Compound coptis chinensis liquid |
-
2019
- 2019-04-24 CN CN201910333463.2A patent/CN109876050A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1091947A (en) * | 1993-05-05 | 1994-09-14 | 朱吉林 | Photoelectric glasses for myoporthosis |
| CN103054998A (en) * | 2013-01-29 | 2013-04-24 | 陆杰 | Compound coptis chinensis liquid |
Non-Patent Citations (1)
| Title |
|---|
| 李秀才: "《常见病自然疗法》", 31 August 2017, 中国医药科技出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110227122A (en) * | 2019-07-31 | 2019-09-13 | 郑州巨人生化集团有限公司 | A kind of Chinese medicine external composition and preparation method thereof for eliminating fundus macular degeneration |
| CN110433232A (en) * | 2019-09-03 | 2019-11-12 | 深圳市中康生物制药有限公司 | A kind of compound huang lian granules of external application and preparation method thereof |
| CN112891439A (en) * | 2019-11-18 | 2021-06-04 | 惠州市华达生物科技有限公司 | Compound pipewort liquid |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102327515B (en) | Method for preparing traditional Chinese medicine (TCM) lotion for treating edema bedsore | |
| CN109620909A (en) | Chinese medicine composition, Chinese medicine eye mask and its preparation and application | |
| CN106901896A (en) | A kind of detoxifying health-care eyeshade | |
| CN109876050A (en) | Compound astragalus membranaceus liquid | |
| CN111035748A (en) | Traditional Chinese medicine composition for improving myopia, external application preparation for improving myopia and eye patch for improving myopia | |
| CN103520655B (en) | Traditional Chinese medicine composition for treating psoriasis vulgaris and preparation method thereof | |
| CN100364593C (en) | Oral liquid for promoting eyesight and protecting eye | |
| CN100459958C (en) | Chinese medicine heat therapy eyeshade and its medicine | |
| CN102139032B (en) | Traditional Chinese medicine for treating intervertebral disc protrusion, hyperosteogeny and rheumatoid disease | |
| CN104189307A (en) | Traditional Chinese medicine for treating deafness and tinnitus and preparation method thereof | |
| CN103520649A (en) | Traditional Chinese medicine for treating facial neuritis | |
| CN102836316B (en) | Chinese medicine preparation for treating amblyopia | |
| CN107929670A (en) | A kind of Medicated eye-mask for treating eye-blurred and preparation method thereof | |
| CN114470049A (en) | Plaster for treating blood stasis arthralgia and preparation and use methods thereof | |
| CN106362089A (en) | External medicine for treating eye diseases | |
| CN110585356A (en) | Traditional Chinese medicine formula for improving eyesight of teenagers and using method | |
| CN102626503B (en) | Chinese medicinal oral liquid for smoothing heart and enhancing intelligence | |
| CN106491730A (en) | A kind of treat Chinese medicine composition of glaucoma and preparation method thereof | |
| CN118680978A (en) | An external composition for relieving visual fatigue and preventing myopia and a preparation method thereof | |
| CN117599149A (en) | A Chinese medicinal composition for improving eyesight, and its preparation method | |
| CN106109630A (en) | For treating the Chinese medicine composition of cervical spondylosis | |
| CN106215133A (en) | A kind of can effective Chinese medicine composition treating cervical spondylosis and preparation method thereof | |
| CN104189603A (en) | Traditional Chinese medicine composition for treating vertigo | |
| CN104771739A (en) | Traditional Chinese medicine composition for treating climacteric syndrome | |
| CN114699470A (en) | Liquid for relaxing channels, dredging collaterals and relieving pain and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20190614 |
|
| RJ01 | Rejection of invention patent application after publication |